GNTIAlternative Names: 5'-Guanidinylnaltrindole
Latest Information Update: 20 Jun 2001
At a glance
- Originator University of Minnesota
- Class Anorectics
- Mechanism of Action Opioid kappa receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 20 Jun 2001 Discontinued-Preclinical for Obesity in USA (Unknown route)
- 17 Dec 1998 New profile
- 17 Dec 1998 Preclinical development for Obesity in USA (Unknown route)